Skip to main content
. 2017 Aug 11;12(8):e0178763. doi: 10.1371/journal.pone.0178763

Fig 3. CMV+GVHD cross reactivity potential.

Fig 3

Patient-specific peak CMV peptide matches intersecting peak alloreactive peptides (IC50<500 nM) as a cross-reactivity potential stratified by donor type contained within each DRP alloreactive peptide library.